comparemela.com

Latest Breaking News On - டாரோ மருந்து தொழில்கள் - Page 1 : comparemela.com

Sun Pharma Q1 results: Reports consolidated PAT of Rs 1,444 crore, meets estimates; revenues rise 28%

Sun Pharma Q1 results: Reports consolidated PAT of Rs 1,444 crore, meets estimates; revenues rise 28% SECTIONS Sun Pharma Q1 results: Reports consolidated PAT of Rs 1,444 crore, meets estimates; revenues rise 28%ETMarkets.com Last Updated: Jul 30, 2021, 02:33 PM IST Share Synopsis The company’s consolidated revenues in the quarter rose 28 per cent year-on-year to Rs 9,719 crore, which was sharply above analysts’ expectations. Agencies Analysts had expected the company to report consolidated net profit of Rs 1,470 crore for the reported quarter. MUMBAI: Sun Pharmaceutical Industries today reported a consolidated net profit of Rs 1,444 crore for the quarter ended June as against a consolidated net loss of Rs 1,655 crore in the year-ago quarter. Analysts had expected the company to report consolidated net profit of Rs 1,470 crore for the reported quarter.

Taro: Fiscal Q1 Earnings Snapshot

Taro: Fiscal Q1 Earnings Snapshot July 27, 2021 FacebookTwitterEmail HAIFA BAY, Israel (AP) Taro Pharmaceutical Industries Ltd. (TARO) on Tuesday reported a loss of $18.8 million in its fiscal first quarter. On a per-share basis, the Haifa Bay, Israel-based company said it had a loss of 50 cents. Earnings, adjusted for non-recurring costs, came to $1.09 per share. The drug maker posted revenue of $147.1 million in the period. Taro shares have fallen nearly 4% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $70.74, an increase of nearly 9% in the last 12 months. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TARO at https://www.zacks.com/ap/TARO

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.